https://crstoday.com/news/alnylam-vir-to-advance-experimental-rnai-therapeutic-vir-2703-as-potential-covid-19-treatment/2477702/daily0.7https://crstoday.com/news/sightglass-vision-announces-rd-webinar-featuring-leading-myopia-experts/2477704/daily0.7https://crstoday.com/news/american-academy-of-ophthalmology-releases-covid-19-survey/2477701/daily0.7https://crstoday.com/news/age-related-dna-modifications-linked-to-eye-disease-susceptibility/2477700/daily0.7https://crstoday.com/news/nih-mobilizes-national-innovation-initiative-for-covid-19-diagnostics/2477698/daily0.7https://crstoday.com/news/cms-eases-requirements-for-covid-19-tests-boosts-payments-for-telephonic-visits/2477699/daily0.7https://crstoday.com/news/kala-pharmaceuticals-resubmits-nda-for-eysuvis-for-dry-eye-disease/2477696/daily0.7https://crstoday.com/news/santen-introduces-eco-friendly-biomass-plastic-eyedrop-bottles/2477697/daily0.7https://crstoday.com/news/roche-wins-us-nod-for-covid-19-antibody-test-aims-to-boost-output/2477694/daily0.7https://crstoday.com/news/fda-issues-emergency-use-authorization-for-potential-covid-19-treatment/2477695/daily0.7https://crstoday.com/news/yoga-with-dr-richardson/2477693/daily0.7https://crstoday.com/news/covid-19-evolving-conditions-in-asia/2477692/daily0.7https://crstoday.com/news/more-than-1-million-people-have-recovered-from-covid-19-worldwide/2477691/daily0.7https://crstoday.com/news/remdesivir-maker-moving-very-quickly-with-fda-on-possible-coronavirus-use-ceo-says/2477690/daily0.7https://crstoday.com/news/checkedup-launches-virtual-visits-telehealth-platform-for-specialty-care/2477689/daily0.7https://crstoday.com/news/as-covid-19-shutters-practices-virtual-doc-patient-activity-soars/2477685/daily0.7https://crstoday.com/news/certain-hospital-systems-eye-a-restart-of-elective-procedures-canceled-due-to-covid-19/2477687/daily0.7https://crstoday.com/news/coopervision-extends-deadline-for-science-and-technology-awards-proposals/2477688/daily0.7https://crstoday.com/news/an-imaging-method-to-help-us-see-behind-our-eyes/2477684/daily0.7https://crstoday.com/news/higher-rates-of-covid-19-infection-and-death-for-people-with-parkinson-disease/2477683/daily0.7https://crstoday.com/news/covideyefacts-org-adds-more-resources-for-ecps-and-wearers/2477681/daily0.7https://crstoday.com/news/market-scope-new-refractive-atlas-identifies-location-of-lvc-candidates-and-refractive-surgeons/2477682/daily0.7https://crstoday.com/news/elt-sights-extra-excimer-laser-trabeculostomy-procedure-receives-new-cpt-codes/2477680/daily0.7https://crstoday.com/news/quest-labcorp-launch-nationwide-covid-19-antibody-testing-in-pharmacies-and-online/2477677/daily0.7https://crstoday.com/news/mojo-vision-raises-additional-51-million-to-develop-smart-contact-lens/2477678/daily0.7https://crstoday.com/news/a-next-generation-coronavirus-test-raises-hopes-and-concerns/2477679/daily0.7https://crstoday.com/news/covid-19-can-clinical-trials-proceed/2477676/daily0.7https://crstoday.com/news/quest-diagnostics-launches-first-consumer-ordered-covid-19-antibody-test/2477674/daily0.7https://crstoday.com/news/cxl-ophthalmics-appoints-jonathan-h-talamo-md-to-its-board-of-managers/2477675/daily0.7https://crstoday.com/news/gilead-says-early-results-of-coronavirus-drug-trial-show-improvement-with-shorter-remdesivir-treatment/2477673/daily0.7https://crstoday.com/news/covid-19-finding-opportunity-in-crisis/2477672/daily0.7https://crstoday.com/news/aao-expands-partnership-with-verana-health-to-include-ehr-data-integration-and-mips-reporting-for-the-iris-registry/2477671/daily0.7https://crstoday.com/news/istar-medical-biocompatible-migs-implant-shows-outstanding-efficacy-in-glaucoma-patients/2477668/daily0.7https://crstoday.com/news/ooss-aao-and-ascrs-develop-checklist-for-reopening-ophthalmic-surgery-centers/2477669/daily0.7https://crstoday.com/news/aaps-hydroxychloroquine-has-about-90-percent-chance-of-helping-covid-19-patients/2477670/daily0.7https://crstoday.com/news/widely-used-surgical-masks-are-putting-health-care-workers-at-serious-risk/2477666/daily0.7https://crstoday.com/news/locked-down-in-love-for-now/2477667/daily0.7https://crstoday.com/news/european-leaders-who-team-up-on-8b-pandemic-vaccine-response/2477664/daily0.7https://crstoday.com/news/congress-urges-fda-to-better-police-evaluate-covid-19-antibody-tests/2477665/daily0.7https://crstoday.com/news/in-race-for-a-coronavirus-vaccine-an-oxford-group-leaps-ahead/2477663/daily0.7https://crstoday.com/news/clearside-biomedical-revises-nda-resubmission-timeline-and-xipere-commercial-partnership-with-bausch-health/2477660/daily0.7https://crstoday.com/news/sanofi-regeneron-and-roche-report-mixed-results-for-potential-covid-19-treatments/2477661/daily0.7https://crstoday.com/news/bvi-names-david-murray-as-chief-financial-officer/2477662/daily0.7https://crstoday.com/news/ocular-therapeutix-announces-topline-results-of-phase-3-clinical-trial-of-dextenza-for-allergic-conjunctivitis/2477659/daily0.7https://crstoday.com/news/new-dates-announced-for-bmc-virtual-spring-symposium/2477658/daily0.7https://crstoday.com/news/seniors-with-covid-19-show-unusual-symptoms-doctors-say/2477655/daily0.7https://crstoday.com/news/i-med-pharma-gains-health-canada-approval-for-eeye-laser/2477656/daily0.7https://crstoday.com/news/ziemer-receives-ce-mark-clearance-for-two-new-applications-for-the-femto-ldv-z8-laser-platform/2477654/daily0.7https://crstoday.com/news/cdc-adds-6-symptoms-to-its-covid-19-list/2477651/daily0.7https://crstoday.com/news/cms-suspends-advance-payments-to-providers-is-reevaluating-accelerated-payments-for-hospitals/2477652/daily0.7https://crstoday.com/news/sightglass-vision-unveils-topline-data-from-study-of-novel-eyeglasses-designed-to-control-myopia-in-children/2477653/daily0.7https://crstoday.com/news/covid-19-updates-from-europe/2477650/daily0.7https://crstoday.com/news/fda-cautions-against-use-of-hydroxychloroquine-or-chloroquine-for-covid-19-outside-of-the-hospital-setting/2477649/daily0.7https://crstoday.com/news/david-rostov-joins-corneagen-as-chief-financial-officer/2477648/daily0.7https://crstoday.com/news/market-scope-covid-19-fallout-could-reshape-ophthalmology-in-india/2477647/daily0.7https://crstoday.com/news/national-vision-announces-plans-for-the-gradual-reopening-of-retail-locations-to-the-public/2477644/daily0.7https://crstoday.com/news/who-accidently-leaks-disappointing-results-of-chinese-clinical-trial-testing-gileads-remdesivir-in-severe-covid-19/2477645/daily0.7https://crstoday.com/news/covid-19-vaccine-protects-monkeys-from-new-coronavirus-chinese-biotech-reports/2477646/daily0.7https://crstoday.com/news/ambulatory-surgery-centers-eligible-for-new-relief-grant-funds-on-april-24/2477642/daily0.7https://crstoday.com/news/covid-19-the-impact-on-training-programs/2477643/daily0.7https://crstoday.com/news/lancet-neurology-publishes-pivotal-phase-3-data-for-genentechs-satralizumab-for-nmosd/2477640/daily0.7https://crstoday.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/daily0.7https://crstoday.com/news/optometry-life-interrupted/2477638/daily0.7https://crstoday.com/news/fda-authorizes-first-test-for-patient-at-home-sample-collection/2477635/daily0.7https://crstoday.com/news/a-disaster-roche-ceos-verdict-on-some-covid-19-antibody-tests/2477636/daily0.7https://crstoday.com/news/in-sickest-covid-19-patients-underlying-conditions-are-common-large-study-finds/2477637/daily0.7https://crstoday.com/news/johnson-johnson-vision-appoints-rajesh-k-rajpal-md-chief-medical-officer/2477634/daily0.7https://crstoday.com/news/hhs-heres-how-remaining-70b-in-covid-19-funding-will-be-distributed-to-providers/2477633/daily0.7https://crstoday.com/news/covid-19-fellowship-and-training-in-flux/2477632/daily0.7https://crstoday.com/news/visibly-offers-free-telehealth-vision-tests-during-covid-19-pandemic/2477627/daily0.7https://crstoday.com/news/nih-panel-issues-covid-19-treatment-guidelines-highlighting-lack-of-data-for-antiviral-immunomodulatory-therapies-under-investigation/2477628/daily0.7https://crstoday.com/news/congress-reaches-deal-that-includes-75b-for-hospitals-after-requests-from-providers/2477629/daily0.7https://crstoday.com/news/q-biomed-initiates-rapid-development-of-novel-covid-19-therapeutics/2477631/daily0.7https://crstoday.com/news/covid-19-forecasting-the-new-normal/2477626/daily0.7https://crstoday.com/news/student-loans-unemployment-and-finding-a-job/2477625/daily0.7https://crstoday.com/news/fda-cdc-nih-to-begin-validating-covid-19-antibody-tests-as-more-enter-the-market/2477624/daily0.7https://crstoday.com/news/novartis-acquires-amblyotech-a-provider-of-digital-therapy-for-treatment-of-amblyopia/2477623/daily0.7https://crstoday.com/news/alexion-to-investigate-effects-of-c5-inhibition-with-ultomiris-in-hospitalized-patients-with-severe-covid-19/2477621/daily0.7https://crstoday.com/news/thirona-launches-ai-powered-solution-for-covid-19-analysis-on-ct-scans/2477622/daily0.7https://crstoday.com/news/cms-releases-guidance-for-how-health-systems-can-restart-elective-procedures/2477620/daily0.7https://crstoday.com/news/aao-survey-reveals-pandemics-dire-effect-on-private-ophthalmic-practices/2477619/daily0.7https://crstoday.com/news/novabay-pharmaceuticals-signs-agreement-to-distribute-covid-19-antibody-rapid-point-of-care-test-to-u-s-healthcare-professionals/2477616/daily0.7https://crstoday.com/news/novartis-to-conduct-study-of-hydroxychloroquine-for-hospitalized-patients-with-covid-19-disease/2477617/daily0.7https://crstoday.com/news/oklahoma-texas-and-alaska-to-begin-allowing-elective-surgeries/2477618/daily0.7https://crstoday.com/news/the-tests-that-could-reopen-the-country-how-they-work/2477614/daily0.7https://crstoday.com/news/how-does-coronavirus-kill-clinicians-trace-a-ferocious-rampage-through-the-body/2477615/daily0.7https://crstoday.com/news/covid-19-crisis-in-latin-america/2477613/daily0.7https://crstoday.com/news/nih-to-launch-public-private-partnership-to-speed-covid-19-vaccine-and-treatment-options/2477612/daily0.7https://crstoday.com/news/aao-releases-statement-regarding-returning-to-ophthalmology-practice/2477611/daily0.7https://crstoday.com/news/haag-streit-group-acquires-majority-stake-in-vrmagic/2477610/daily0.7https://crstoday.com/news/novartis-implementing-programs-to-assist-optometrists-during-covid-19/2477609/daily0.7https://crstoday.com/news/white-house-details-guidelines-for-businesses-hospitals-to-get-back-to-normality/2477606/daily0.7https://crstoday.com/news/how-to-sanitize-n95-masks-for-reuse-nih-study/2477607/daily0.7https://crstoday.com/news/nicox-provides-business-update-and-financial-highlights/2477608/daily0.7https://crstoday.com/news/swedish-biotech-aims-to-create-super-vaccine-for-covid-19-with-karolinska-institute/2477603/daily0.7https://crstoday.com/news/crispr-and-spit-might-be-keys-to-faster-cheaper-easier-tests-for-the-coronavirus/2477604/daily0.7https://crstoday.com/news/federal-guidelines-establish-criteria-for-providing-elective-surgeries-during-reopening-of-economy/2477605/daily0.7https://crstoday.com/news/covid-19-crisis-the-role-of-aao-and-asrs/2477602/daily0.7https://crstoday.com/news/looking-to-ophthalmic-leaders/2477601/daily0.7https://crstoday.com/news/covid-19-urgent-and-emergent-cases-only/2477600/daily0.7https://crstoday.com/news/fda-crants-for-priority-review-approval-for-regenerons-regn-eb3-to-treat-ebola/2477599/daily0.7https://crstoday.com/news/small-business-rescue-loan-program-is-now-out-of-money/2477598/daily0.7https://crstoday.com/news/cms-boosts-medicare-payments-for-high-throughput-covid-19-diagnostic-tests/2477597/daily0.7https://crstoday.com/news/call-for-nominations-issued-for-the-2020-bonnie-strickland-champion-for-childrens-vision-award/2477595/daily0.7https://crstoday.com/news/tearclear-appoints-robert-j-dempsey-chief-executive-officer/2477596/daily0.7https://crstoday.com/news/new-covid-19-clinical-trial-supported-by-octapharma-usa/2477593/daily0.7https://crstoday.com/news/covid-19-crisis-in-asia/2477592/daily0.7https://crstoday.com/news/safety-net-hospitals-to-congress-give-us-more-targeted-funding-to-combat-covid-19/2477591/daily0.7https://crstoday.com/news/leo-lens-pharma-appoints-dan-myers-ceo/2477589/daily0.7https://crstoday.com/news/healthverity-patient-confidence-index-aims-to-become-bellwether-measure-of-impact-to-non-covid-19-patients-and-physicians/2477590/daily0.7https://crstoday.com/news/telemedicine-watch-and-learn/2477587/daily0.7https://crstoday.com/news/fda-quickly-authorizes-its-2nd-blood-filtering-device-for-covid-19/2477585/daily0.7https://crstoday.com/news/im-laid-off-furloughed-fired-now-what/2477584/daily0.7https://crstoday.com/news/ophthalmic-companies-announce-chances-to-operations-and-guidance/2477582/daily0.7https://crstoday.com/news/ascrs-to-host-eyecelerator-livestream-meeting/2477581/daily0.7https://crstoday.com/news/nidek-launches-the-cp-9-chart-projector/2477580/daily0.7https://crstoday.com/news/vision-expo-announces-virtual-eye2eye-series-launching-april-15/2477579/daily0.7https://crstoday.com/news/aldeyra-therapeutics-announces-potential-of-adx-629-to-treat-covid-19-patients/2477578/daily0.7https://crstoday.com/news/astrazeneca-to-study-btk-inhibitor-calquence-as-treatment-for-cytokine-storm-associated-with-covid-19-infection/2477575/daily0.7https://crstoday.com/news/fah-hospital-closures-loom-if-feds-dont-distribute-more-cash-to-fight-covid-19/2477576/daily0.7https://crstoday.com/news/bausch-lomb-announces-publication-of-10-year-armor-study-results-on-ocular-antibiotic-resistance/2477577/daily0.7https://crstoday.com/news/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/2477574/daily0.7https://crstoday.com/news/data-visualization-tool-examines-community-factors-underlying-covid-19-outcomes/2477572/daily0.7https://crstoday.com/news/staar-surgical-provides-covid-19-business-update/2477570/daily0.7https://crstoday.com/news/ocular-therapeutix-provides-business-update-and-response-to-covid-19-global-pandemic/2477571/daily0.7https://crstoday.com/news/telehealths-not-getting-switched-off-after-covid-19-crisis/2477566/daily0.7https://crstoday.com/news/new-peer-reviewed-paper-offers-advice-to-contact-lens-practitioners-during-covid-19-pandemic/2477569/daily0.7https://crstoday.com/news/optometrys-meeting-cancelled-due-to-covid-19/2477565/daily0.7https://crstoday.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/daily0.7https://crstoday.com/news/telemedicine-in-the-covid-era-this-is-not-a-test/2477564/daily0.7https://crstoday.com/news/ama-releases-covid-19-volunteer-guide-for-health-care-professionals/2477561/daily0.7https://crstoday.com/news/cms-relaxes-rules-to-boost-capacity-of-providers-as-facilities-tackle-covid-19-outbreak/2477562/daily0.7https://crstoday.com/news/pfizer-aims-to-start-clinical-testing-of-lead-compound-against-sars-cov-2-in-third-quarter/2477560/daily0.7https://crstoday.com/news/aerie-pharmaceuticals-provides-2020-company-and-guidance-update-associated-with-covid-19/2477559/daily0.7https://crstoday.com/news/covid-19-what-to-do-with-your-practice/2477558/daily0.7https://crstoday.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment/2477557/daily0.7https://crstoday.com/news/glaukos-provides-update-on-covid-19-impact-and-preliminary-net-sales-range-for-first-quarter/2477552/daily0.7https://crstoday.com/news/novavax-accelerates-initiation-of-covid-19-vaccine-trial-to-mid-may/2477554/daily0.7https://crstoday.com/news/gottlieb-mostashari-propose-national-covid-19-surveillance-system/2477555/daily0.7https://crstoday.com/news/tracking-the-covid-19-cytokine-storm/2477551/daily0.7https://crstoday.com/news/cms-has-doled-out-nearly-34b-in-advance-accelerated-payments-to-providers-to-combat-covid-19/2477550/daily0.7https://crstoday.com/news/nicox-outlines-plans-to-progress-ncx-4251-into-phase-2b-trial-following-positive-meeting-with-fda/2477548/daily0.7https://crstoday.com/news/icare-usa-completes-merger-with-centervue/2477549/daily0.7https://crstoday.com/news/roche-canada-launches-data-science-coalition-to-advance-covid-19-solutions/2477544/daily0.7https://crstoday.com/news/docs-push-hhs-to-offer-direct-funding-as-finances-slump-due-to-covid-19/2477545/daily0.7https://crstoday.com/news/apply-for-the-sba-paycheck-protection-program/2477546/daily0.7https://crstoday.com/news/the-small-business-owners-guide-to-the-cares-act/2477547/daily0.7https://crstoday.com/news/managing-your-staff-and-practice-during-a-pandemic/2479526/daily0.7https://crstoday.com/news/experts-provide-update-on-medicare-waivers-and-other-regulatory-provisions-during-covid-19/2479527/daily0.7https://crstoday.com/news/ama-suspends-plans-for-annual-meeting-in-chicago/2479528/daily0.7https://crstoday.com/news/aaopt-and-asco-establish-virtual-clinical-training-program-to-keep-optometry-students-on-graduation-track/2477542/daily0.7https://crstoday.com/news/teclens-donates-10000-ppe-face-shields-to-workers-on-front-line/2477543/daily0.7https://crstoday.com/news/mobius-therapeutics-continues-production-and-distribution-of-mitosol/2477540/daily0.7https://crstoday.com/news/ortho-eurofins-lay-out-plans-for-high-throughput-covid-19-antibody-blood-testing/2477541/daily0.7https://crstoday.com/news/mayo-clinics-jonathan-holmes-md-appointed-uarizona-chair-of-ophthalmology/2477537/daily0.7https://crstoday.com/news/alcon-provides-update-on-covid-19/2477538/daily0.7https://crstoday.com/news/mundipharma-donates-betadine-products-to-hospitals-in-philippines-thailand-and-vietnam-to-support-the-fight-against-covid-19/2477539/daily0.7https://crstoday.com/news/glaxosmithkline-takes-250-million-stake-in-vir-as-companies-pair-up-to-develop-coronavirus-treatments/2477536/daily0.7https://crstoday.com/news/covid-19-and-medicare/2477534/daily0.7https://crstoday.com/news/fda-issues-new-policy-for-remote-ophthalmic-assessment-and-monitoring-devices-during-covid-19/2477535/daily0.7https://crstoday.com/news/aao-malaria-drugs-for-covid-19-will-not-blind-you/2477533/daily0.7https://crstoday.com/news/inovio-initiates-phase-1-clinical-trial-of-its-covid-19-vaccine-and-plans-first-dose-today/2477532/daily0.7https://crstoday.com/news/protokinetix-aagp-exhibits-efficacy-and-safety-in-model-of-dry-eye-disease/2479530/daily0.7https://crstoday.com/news/eu-body-backs-compassionate-use-of-gileads-remdesivir-for-covid-19/2479531/daily0.7https://crstoday.com/news/blephex-announces-appeal-victory-in-patent-litigation-with-myco-industries/2479532/daily0.7https://crstoday.com/news/covid-19-checking-in-with-london/2479533/daily0.7https://crstoday.com/news/covid-19-in-europe-reports-from-the-ground/2477531/daily0.7https://crstoday.com/news/first-hand-accounts-from-ods-who-tested-positive-with-covid-19/2477530/daily0.7https://crstoday.com/news/wsj-trump-administration-plans-to-pay-hospitals-to-treat-uninsured-coronavirus-patients/2477529/daily0.7https://crstoday.com/news/luxottica-to-donate-hundreds-of-thousands-of-medical-masks-outlines-covid-19-safety-and-relief-efforts/2477526/daily0.7https://crstoday.com/news/incyte-novartis-to-evaluate-jak-inhibitor-ruxolitinib-for-severe-covid-19-patients/2477527/daily0.7https://crstoday.com/news/hydroxychloroquine-for-the-treatment-and-prevention-of-covid-19/2477524/daily0.7https://crstoday.com/news/new-guidance-issued-on-ppp-loans/2477525/daily0.7https://crstoday.com/news/matterhackers-covid-19-response-registry-medical-facilities-and-government-agencies-usa/2477523/daily0.7https://crstoday.com/news/provider-initiative-to-help-ease-financial-and-administrative-stress-during-coronavirus-pandemic/2477522/daily0.7https://crstoday.com/news/2020-world-ophthalmology-congress-cancelled-virtual-program-planned/2479534/daily0.7https://crstoday.com/news/bvi-donating-personal-protective-equipment-to-help-protect-the-covid-19-frontline/2477520/daily0.7https://crstoday.com/news/ootg-webcast-experts-provide-advice-on-how-to-handle-staff-and-ensure-business-survival-when-the-practice-closes/2477517/daily0.7https://crstoday.com/news/prevent-blindness-provides-free-eye-health-curriculum-to-educators-to-help-children-learn-about-importance-of-eye-care/2477518/daily0.7https://crstoday.com/news/fda-calls-for-withdrawal-of-ranitidine-products-as-review-finds-contaminant-could-pose-risk/2477519/daily0.7https://crstoday.com/news/china-gives-green-light-to-allergans-xen-registration-for-the-surgical-management-of-refractory-glaucoma/2477514/daily0.7https://crstoday.com/news/sightglass-vision-reports-positive-interim-data-from-pivotal-clinical-trial-of-novel-eyeglasses-for-myopia-management-in-children/2477515/daily0.7https://crstoday.com/news/philadelphia-teen-fires-up-his-3d-printers-to-create-face-shields-to-donate-to-hospitals/2477516/daily0.7https://crstoday.com/news/covid-19-reports-from-us-hot-zones/2477513/daily0.7https://crstoday.com/news/fda-launches-program-to-speed-development-of-covid-19-treatments/2477511/daily0.7https://crstoday.com/news/tatsuya-kaihara-appointed-ceo-of-santen-inc-and-head-of-north-america-business-of-santen-pharmaceutical/2477510/daily0.7https://crstoday.com/news/mallinckrodt-and-novoteris-receive-clearance-from-health-canada-to-start-pilot-trial-of-inhaled-nitric-oxide-therapy-for-covid-19/2477506/daily0.7https://crstoday.com/news/allergan-covid-19-response-program-enhancements/2477507/daily0.7https://crstoday.com/news/cad4covid-x-ray-analysis-for-quick-triage-in-corona-crisis/2477508/daily0.7https://crstoday.com/news/covid-19-when-the-practice-closes/2477505/daily0.7https://crstoday.com/news/cms-provides-regulatory-relief-on-staffing-paperwork-as-covid-19-cases-surge/2477504/daily0.7https://crstoday.com/news/ophthalmologists-share-their-strategies-for-managing-stress/2477502/daily0.7https://crstoday.com/news/second-sight-announces-employee-layoffs-intent-to-wind-down-operations/2477503/daily0.7https://crstoday.com/news/covid-19-updates-from-capitol-hill/2483611/daily0.7https://crstoday.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/daily0.7https://crstoday.com/news/cms-will-make-expedited-advance-payments-to-medicare-providers/2477498/daily0.7https://crstoday.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/daily0.7https://crstoday.com/news/how-ophthalmologists-are-changing-their-surgical-routines-part-2/2477491/daily0.7https://crstoday.com/news/how-ophthalmologists-are-changing-their-surgical-routines/2477492/daily0.7https://crstoday.com/news/ootg-webcast-weathering-the-storm-and-supporting-staff/2477488/daily0.7https://crstoday.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/daily0.7https://crstoday.com/news/us-department-of-labor-provides-guidance-on-paid-sick-and-family-leave/2477487/daily0.7https://crstoday.com/news/eyevance-pharmaceuticals-launches-zerviate-in-the-united-states/2477486/daily0.7https://crstoday.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/daily0.7https://crstoday.com/news/vertex-aims-for-virtual-clinic-visits-to-keep-ongoing-studies-on-track-amid-covid-19-pandemic/2477483/daily0.7https://crstoday.com/news/sight-sciences-announces-publication-of-historical-review-of-canal-surgery/2477484/daily0.7https://crstoday.com/news/university-of-minnesota-seeks-to-enroll-health-care-workers-for-covid-19-clinical-trial/2477477/daily0.7https://crstoday.com/news/aao-releases-list-of-urgent-and-emergent-ophthalmic-procedures/2477478/daily0.7https://crstoday.com/news/abbott-launches-molecular-point-of-care-test-to-detect-novel-coronavirus-in-as-little-as-five-minutes/2477479/daily0.7https://crstoday.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/daily0.7https://crstoday.com/news/how-covid-19-affects-us-retina-practices/2477494/daily0.7https://crstoday.com/news/covid-19-surviving-the-storm-and-supporting-the-staff/2477490/daily0.7https://crstoday.com/news/house-passes-2-trillion-coronavirus-stimulus-package/2477476/daily0.7https://crstoday.com/news/zeiss-releases-company-update-on-covid-19-pandemic/2477475/daily0.7https://crstoday.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/daily0.7https://crstoday.com/news/aao-updates-guidance-on-use-of-chloroquine-and-hydroxychloroquine/2477473/daily0.7https://crstoday.com/news/nyu-med-school-will-graduate-students-early-to-help-new-york-fight-coronavirus/2477471/daily0.7https://crstoday.com/news/european-glaucoma-society-postpones-annual-congress/2477472/daily0.7https://crstoday.com/news/uk-commits-210-million-toward-global-efforts-to-find-covid-19-vaccine/2477469/daily0.7https://crstoday.com/news/prevent-blindness-releases-message-to-eye-care-patients-regarding-the-covid-19-pandemic/2477470/daily0.7https://crstoday.com/news/live-webcast-covid-19-impact-on-retina-practices/2477468/daily0.7https://crstoday.com/news/covid-19-roundtable-how-retina-doctors-from-around-the-united-states-are-adjusting-their-clinics/2477467/daily0.7https://crstoday.com/news/modernizing-medicine-launches-telehealth-enabled-ehr/2477466/daily0.7https://crstoday.com/news/us-ecps-business-concerns-and-stress-levels-grow-as-coronavirus-pandemic-impact-widens/2477464/daily0.7https://crstoday.com/news/fda-grants-gilead-request-to-drop-orphan-drug-designation-for-potential-covid-19-treatment-remdesivir/2477465/daily0.7https://crstoday.com/news/senate-passes-coronavirus-stimulus-bill-house-expected-to-follow-suit/2477462/daily0.7https://crstoday.com/news/aldeyra-to-screen-clinical-stage-compounds-for-activity-in-covid-19-infection/2477461/daily0.7https://crstoday.com/news/microsurgical-technology-mst-announces-the-acquisition-of-ip-and-assets-of-iriss-medical-technologies-limited/2477460/daily0.7https://crstoday.com/news/study-low-risk-of-coronavirus-spreading-through-tears/2477459/daily0.7https://crstoday.com/news/bausch-health-donates-health-care-products-and-supplies-in-response-to-covid-19-pandemic/2477458/daily0.7https://crstoday.com/news/novabay-pharmaceuticals-announces-the-availability-of-kn95-disposable-masks-on-avenova-com/2477457/daily0.7https://crstoday.com/news/white-house-and-senate-strike-a-deal-on-historic-2-trillion-coronavirus-stimulus-bill/2477454/daily0.7https://crstoday.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/daily0.7https://crstoday.com/news/american-college-of-surgeons-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19/2477456/daily0.7https://crstoday.com/news/fda-authorizes-hand-held-covid-19-diagnostic-test/2477452/daily0.7https://crstoday.com/news/zeiss-medical-technology-launches-new-website-zeiss-med-support-now/2477453/daily0.7https://crstoday.com/news/covid-19-ophthalmologists-turned-patients/2477493/daily0.7https://crstoday.com/news/many-drugs-already-approved-by-fda-may-have-promise-against-covid-19/2477451/daily0.7https://crstoday.com/news/ascrs-to-host-webinars-for-eye-care-professionals-dealing-with-covid-19-outbreak/2477450/daily0.7https://crstoday.com/news/glaukos-provides-covid-19-pandemic-update/2477449/daily0.7https://crstoday.com/news/imprimisrx-to-provide-healthcare-professionals-with-telemedicine-services/2477446/daily0.7https://crstoday.com/news/covid-19-working-with-barda-and-fda-on-covid-19-countermeasures/2477443/daily0.7https://crstoday.com/news/fda-clamps-down-on-at-home-coronavirus-testing-citing-fake-products-and-bad-actors/2477444/daily0.7https://crstoday.com/news/the-vision-council-releases-midpoint-march-covid-19-optical-impact-consumer-study-to-members/2477445/daily0.7https://crstoday.com/news/covid-19-trials-in-transmission/2477495/daily0.7https://crstoday.com/news/fda-approves-genentechs-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/2477442/daily0.7https://crstoday.com/news/ophthalmology-off-the-grid-on-covid-19-part-2/2477441/daily0.7https://crstoday.com/news/my-eyelab-and-stanton-optical-to-offer-only-telehealth-in-response-to-covid-19-crisis/2477438/daily0.7https://crstoday.com/news/fed-unveils-major-expansion-of-market-intervention/2477439/daily0.7https://crstoday.com/news/coronavirus-vaccine-trials-could-start-in-uk-within-a-month/2477440/daily0.7https://crstoday.com/news/sifi-provides-italian-hospital-products-to-treat-ocular-discomfort-and-prevent-potential-risks-of-infection/2477436/daily0.7https://crstoday.com/news/arnold-porter-to-host-webinar-on-proposed-cares-act/2477437/daily0.7https://crstoday.com/news/cms-announces-relief-for-clinicians-providers-hospitals-and-facilities-participating-in-quality-reporting-programs-in-response-to-covid-19/2477433/daily0.7https://crstoday.com/news/doctors-turn-to-malaria-drugs-as-potential-coronavirus-treatment/2477434/daily0.7https://crstoday.com/news/adaptive-biotechnologies-and-microsoft-expand-partnership-to-decode-covid-19-immune-response-and-provide-open-data-access/2477435/daily0.7https://crstoday.com/news/novartis-mylan-and-teva-to-supply-tens-of-millions-of-chloroquine-tablets-to-fight-covid-19/2477430/daily0.7https://crstoday.com/news/new-podcast-addresses-covid-19-impact/2477431/daily0.7https://crstoday.com/news/vit-buckle-society-annual-meeting-cancelled/2477432/daily0.7https://crstoday.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/daily0.7https://crstoday.com/news/a-majority-of-ecps-reduce-office-hours-expect-lower-revenues-as-covid-19-situation-expands-jobson-research-survey-finds/2477428/daily0.7https://crstoday.com/news/asrs-releases-guidelines-to-help-retina-practices-navigate-covid-19-pandemic/2477427/daily0.7https://crstoday.com/news/my-eyelab-and-stanton-optical-shifts-to-solely-telehealth-eyecare-to-serve-community/2477426/daily0.7https://crstoday.com/news/first-phase-clinical-trials-of-chinas-first-covid-19-vaccine-to-last-nine-months/2477423/daily0.7https://crstoday.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/daily0.7https://crstoday.com/news/hiv-drug-failed-to-help-patients-with-severe-cases-of-covid-19/2477425/daily0.7https://crstoday.com/news/the-coronavirus-crisis-what-companies-need-to-know-about-congressional-actions-to-date/2477419/daily0.7https://crstoday.com/news/facing-the-covid-19-threat-more-optical-retailers-and-ecps-make-the-tough-decision-to-temporarily-close-locations-or-modify-services/2477420/daily0.7https://crstoday.com/news/topcon-announces-customer-initiatives-to-combat-global-covid-19-crisis/2477421/daily0.7https://crstoday.com/news/trump-touts-drug-that-fda-says-isnt-yet-approved-for-virus/2477422/daily0.7https://crstoday.com/news/bayer-partners-with-u-s-government-on-major-product-donation-to-fight-coronavirus/2477417/daily0.7https://crstoday.com/news/state-department-to-tell-americans-dont-travel-abroad-come-home-if-overseas/2477418/daily0.7https://crstoday.com/news/retina-specialists-share-how-they-are-adjusting-to-covid-19/2477416/daily0.7https://crstoday.com/news/avellino-expands-production-of-genetic-test-kits-for-coronavirus-detection/2477415/daily0.7https://crstoday.com/news/president-invokes-the-defense-production-act-in-response-to-covid-19/2477413/daily0.7https://crstoday.com/news/cms-recommends-limit-on-nonessential-planned-surgeries-including-postponement-of-cataract-procedures/2477414/daily0.7https://crstoday.com/news/roche-initiates-phase-3-trial-of-actemra-roactemra-in-patients-with-severe-covid-19-pneumonia/2477410/daily0.7https://crstoday.com/news/chinese-official-claims-fujifilms-avigan-clearly-effective-in-treating-covid-19/2477411/daily0.7https://crstoday.com/news/american-academy-of-ophthalmology-urges-members-to-immediately-stop-routine-surgical-and-in-office-visits/2477412/daily0.7https://crstoday.com/news/senate-passes-coronavirus-emergency-aid-sending-plan-to-president/2477409/daily0.7https://crstoday.com/news/quidel-receives-emergency-use-authorization-for-molecular-covid-19-diagnostic-assay/2477407/daily0.7https://crstoday.com/news/lenstec-submits-premarket-approval-application-to-fda-for-sbl3-iol/2477408/daily0.7https://crstoday.com/news/report-japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china/2477406/daily0.7https://crstoday.com/news/first-patient-dosed-in-study-of-modernas-mrna-vaccine-against-covid-19/2477403/daily0.7https://crstoday.com/news/regenerons-novel-covid-19-antibody-program-has-potential-to-enter-human-clinical-studies-by-early-summer/2477404/daily0.7https://crstoday.com/news/sight-sciences-announces-30-million-financing/2477405/daily0.7https://crstoday.com/news/us-ophthalmologists-respond-to-covid-19-outbreak/2477402/daily0.7https://crstoday.com/news/ascrs-officially-cancels-its-annual-meeting/2477401/daily0.7https://crstoday.com/news/eli-lilly-joins-race-to-develop-coronavirus-treatment/2477398/daily0.7https://crstoday.com/news/vision-innovation-partners-announces-suspension-of-most-office-services-warby-parker-informs-customers-of-store-closures-for-two-weeks-due-to-coronavirus/2477399/daily0.7https://crstoday.com/news/roche-begins-shipments-of-first-400000-covid-19-tests-to-laboratories-across-us/2477397/daily0.7https://crstoday.com/news/controversies-in-ophthalmology-europe-cophy-postpones-cophy-eu-meeting/2477396/daily0.7https://crstoday.com/news/aao-provides-updated-guidance-for-outpatient-clinics-and-elective-surgery/2477395/daily0.7https://crstoday.com/news/novartis-asks-workers-in-europe-us-and-canada-to-work-from-home/2477394/daily0.7https://crstoday.com/news/statement-from-the-ambulatory-surgery-center-association-regarding-elective-surgery-and-covid-19/2477393/daily0.7https://crstoday.com/news/ooss-releases-statement-regarding-covid-19-outbreak/2477392/daily0.7https://crstoday.com/news/mass-eye-and-ear-employee-tests-positive-for-coronavirus/2477390/daily0.7https://crstoday.com/news/covid-19-what-can-the-world-learn-from-italy/2477391/daily0.7https://crstoday.com/news/alirocumab-may-cause-scleritis-with-uveal-effusion/2477386/daily0.7https://crstoday.com/news/coopervision-seeks-proposals-for-science-and-technology-awards/2477387/daily0.7https://crstoday.com/news/ois-plans-to-hold-anterior-segment-meeting/2477388/daily0.7